Focusing on antitrust, intellectual property, and high-stakes litigation, our extensive teams in the U.S. possess deep knowledge and client-side experience across a range of sectors, including technology, healthcare, life sciences, and consumer products.
What Sets Us Apart
- Antitrust: Our team has a track record of obtaining global clearance of combinations of significant rivals, making us a “go-to” firm for strategic mergers and acquisitions.
- Litigation: We are lead defense counsel to some of the world’s largest companies in high-stakes treble damages, class action, and multi-district litigations, as well as federal and state investigations.
- Intellectual Property: We are experienced trial lawyers who deliver favorable results in patent and trade secret trials, appeals, and before the U.S. Patent Office.
Learn More
About Our Work
Notable Recognitions
Featured Viewpoints
Featured Viewpoints
What Meaningful AI Adoption Looks Like Inside a Law Firm
Podcast
Antitrust Exemptions for Competitor Collaborations in the Spotlight: Recent Uses of the Defense Production Act
Takeaways from the Consero Healthcare General Counsel Forum
Anti-Steering Provisions Remain In Antitrust Limelight As Class Action Lawsuits Proceed Through Court
Henkel/Liquid Nails: The Evidence That Drove the Court’s Merger Decision
What Companies Should Know About California’s COMPETE Act
Survival vs. Antitrust: Inside the FTC’s Strict Standards for "Failing" Hospital Acquisitions
Trying Your Luck: What the Data Show About the Antitrust Division’s Track Record at Trial
On-Demand Webinar
Antitrust After the Midterms: What Comes Next for Enforcement, M&A, and Business Strategy?
How could the 2026 midterm elections reshape U.S. antitrust enforcement and competition policy? View this on-demand webinar discussing the potential shifts in DOJ and FTC priorities, merger review, congressional influence, and what businesses and dealmakers should anticipate through 2028.
